Novavax Aktie
5,60
EUR
-0,39
EUR
-6,51
%
6,53
USD
+0,04
USD
+0,54
%
nachbörslich
Es gab keine Analysen zu dieser Aktie in den letzten sechs Monaten.
Werbung
Kursziele im Branchenvergleich
| Aktie | Buy | Hold | Sell | Ø Kursziel | Abst. Kursziel |
|---|---|---|---|---|---|
| AstraZeneca PLC | 6 | 3 | 0 | 136,60 GBP | +28,12% |
| Bayer | 2 | 7 | 0 | 26,00 EUR | -3,79% |
| BioNTech (ADRs) | 4 | 2 | 0 | 135,33 USD | +28,92% |
| CanSino Biologics Inc. Registered Shs -A- | 0 | 0 | 0 | - | - |
| CureVac | 0 | 2 | 0 | - | - |
| Fresenius Medical Care (FMC) St. | 3 | 5 | 2 | 48,19 EUR | +1,80% |
| Fresenius SE & Co. KGaA (St.) | 8 | 2 | 0 | 49,29 EUR | +14,12% |
| Gilead Sciences Inc. | 0 | 0 | 0 | - | - |
| Inovio Pharmaceuticals Inc | 0 | 0 | 0 | - | - |
| Johnson & Johnson | 0 | 0 | 0 | - | - |
| Moderna Inc | 0 | 2 | 1 | 67,33 USD | +163,52% |
| Novartis AG | 3 | 5 | 1 | 99,75 CHF | +4,37% |
| Novavax Inc. | 0 | 0 | 0 | - | - |
| Pfizer Inc. | 3 | 4 | 0 | 29,17 USD | +21,54% |
| Roche AG (Genussschein) | 3 | 3 | 3 | 279,75 CHF | +6,94% |
| Sanofi S.A. | 6 | 3 | 0 | 116,12 EUR | +36,55% |
| Sinopharm Group Co Ltd (H) | 0 | 0 | 0 | - | - |
| Valneva | 0 | 0 | 0 | - | - |